Ironwood Pharmaceuticals (IRWD) Cash from Operations (2010 - 2026)
Ironwood Pharmaceuticals (IRWD) posted Cash from Operations of 5121000.0 for Q1 2026, down 93.13% sequentially from 74575000.0 in Q4 2025, and down 74.34% YoY from 19954000.0 in Q1 2025.
Ironwood Pharmaceuticals (IRWD) Cash from Operations (2010 - 2026) Analysis & Trends
Ironwood Pharmaceuticals has reported Cash from Operations for 17 years, with the latest figure at 5121000.0 in Q1 2026.
- Quarterly Cash from Operations fell 74.34% year-over-year to 5121000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 112211000.0 (up 42.91% YoY) and the FY2025 annual result came in at 127044000.0, up 22.69% from the prior year.
- Cash from Operations eased to 5121000.0 in Q1 2026 per IRWD's latest filing, from 74575000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 80171000.0 in Q1 2023 and troughed at 15068000.0 in Q2 2025.
- A 5-year average of 40759058.82 and a median of 35834000.0 in 2023 frame the typical range for Cash from Operations.
- The widest YoY moves for Cash from Operations: up 390.17% in 2025, down 145.03% in 2025.
- Over 5 years, Cash from Operations stood at 79182000.0 in 2022, then sank by 54.74% to 35834000.0 in 2023, then slumped by 57.54% to 15214000.0 in 2024, then surged by 390.17% to 74575000.0 in 2025, then sank by 93.13% to 5121000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 5121000.0, 74575000.0, and 47583000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Ironwood Pharmaceuticals | 706.94 Mn | 627.81 Mn | - | 58.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 58.28 Mn |
| Jun 30, 2026 | 58.28 Mn |
| Mar 31, 2026 | 5.12 Mn |
| Mar 31, 2026 | 5.12 Mn |
| Dec 31, 2025 | 74.58 Mn |
| Dec 31, 2025 | 74.58 Mn |
| Sep 30, 2025 | 47.58 Mn |
| Sep 30, 2025 | 47.58 Mn |
| Jun 30, 2025 | -15.07 Mn |
| Jun 30, 2025 | -15.07 Mn |
| Mar 31, 2025 | 19.95 Mn |
| Mar 31, 2025 | 19.95 Mn |
| Dec 31, 2024 | 15.21 Mn |
| Dec 31, 2024 | 15.21 Mn |
| Sep 30, 2024 | 9.89 Mn |
| Sep 30, 2024 | 9.89 Mn |
| Jun 30, 2024 | 33.47 Mn |
| Jun 30, 2024 | 33.47 Mn |
| Mar 31, 2024 | 44.99 Mn |
| Mar 31, 2024 | 44.99 Mn |